As of 2024-09-09, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 106.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -41.7%.
The range of the Relative Valuation is 91.37 - 153.35 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.6x - 49.9x | 35.7x |
| Forward P/E multiples | 35.2x - 58.1x | 39.7x |
| Fair Price | 91.37 - 153.35 | 106.43 |
| Upside | -49.9% - -16.0% | -41.7% |
| Date | P/E |